Coronavirus disease 19 (COVID-19) pandemic has caused an emergency in health systems worldwide. Apart from its apparent morbidity and mortality, COVID-19 has also imposed unique challenges in the management of cancer patients. We report here measures taken by a major oncology Unit in Greece to continue operation of the department while ensuring safety of the patients and health care professionals. The efficacy of these measures could serve as guidance for Oncology departments in view of a second wave of COVID-19 cases.
HuangCWangYLiX, et al.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet2020;
395: 497–506.
2.
Johns Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU), https://coronavirus.jhu.edu/map.html (2020).
3.
WhiteMCHolmanDMBoehmJE, et al.
Age and cancer risk: a potentially modifiable relationship. Am J Prev Med2014;
46: S7–S15.
4.
TangiralaKAppukkuttanSSimmonsS.Costs and healthcare resource utilization associated with hospital admissions of patients with metastatic or nonmetastatic prostate cancer. Am Health Drug Benefits2019;
12: 306–312.
5.
VentoSCainelliF.Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol2003;
4: 595–604.
6.
LiangWGuanWChenR, et al.
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol2020;
21: 335–337.
7.
The LancetO.Safeguarding cancer care in a post-COVID-19 world. Lancet Oncol2020;
21: 603.
8.
MiddletonJLopesHMichelsonK, et al. Planning for a second wave pandemic of COVID-19 and planning for winter. Int J Public Health. https://doi.org/10.1007/s00038-020-01455-7 (2020).
9.
CuriglianoGBanerjeeSCervantesA, et al.; Panel members.
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol2020;
31: 1320–1335.
10.
LiontosMKaparelouMKarofylakisE, et al.
Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19. Gynecol Oncol Rep2020;
33: 100615.
11.
BelkacemiYGrellierNGhithS, et al.
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries. Eur J Cancer2020;
135: 130–146.
12.
TerposEEngelhardtMCookG, et al.
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia2020;
34: 2000–2011.
